People Moves
US Specialist Wealth Firm Names New CEO
The firm, which has a strong focus on serving clients from the medical professions, can claim that more than half of its staff are women, in contrast with much of the financial services space.
US firm, Vestia Personal Wealth Advisors, has appointed Lauren Oschman as chief executive, effective immediately. Oschman has succeeded Tommy Martin who will now focus his efforts as a member of Vestia’s board of directors.
Oschman, who co-founded Vestia in 2018, is based in Nashville, Tennessee.
The firm, which has a number of other offices in the US, oversees more than $500 million in assets under management. It specializes in delivering bespoke financial planning and investment management solutions tailored primarily for high income physicians.
“Our team at Vestia has created and delivered a truly customized approach to caring for the financial lives and interests of our highly complex, hard-working physician clients. That remains our top priority,” Oschman said. “While Tommy set a clear leadership benchmark to measure against, my plan is to double down on our approach to client service, maintaining our accelerated objectives for growth, while leaning into our firm’s value of never letting clients or team members guess.”
Vestia’ has a team of 21 employees and more than 60 per cent are female. Five of the 11 team members who function in advisory roles are female, more than twice the financial industry average.
The business is also looking at offerings for military physicians, urologists, and anesthesiologists.
“Lauren’s ascent to the CEO role has been eagerly anticipated by all of us at Vestia and was never a question of ‘if’ but simply ‘when,’” Martin said.
Martin, along with other entrepreneurs and executives from the healthcare, life sciences, tech and financial services arenas, launched the healthcare venture capital firm, Mammoth Scientific, last May. Since then, Vestia, along with other independent wealth management firms working with Mammoth, can offer their clients access to venture capital and early-stage healthcare investments.
